WHO ICTRP trial
dexmedetomidine with intravenous lidocaine in colonoscopy
IRCT20220706055402N2 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20220706055402N2 |
|---|---|
| Public title | dexmedetomidine with intravenous lidocaine in colonoscopy |
| Scientific title | Comparison of the effect of dexmedetomidine with intravenous lidocaine in patients undergoing colonoscopy under sedation with propofol-fentanyl |
| Primary sponsor | Ahvaz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | colonoscopy,sedation. Failed moderate sedation during procedure;T88.52 |
| Interventions | Intervention 1: Intervention group: Intravenous lidocaine is injected with an initial dose of 1.5 mg/kg and a maintenance dose of 1 mg/kg/h, in addition to propofol 0.5 mg/kg and 1 microgram/kg of fentanyl. Intervention 2: Intervention… |
| Registration date | Feb 11, 2023 |
| Target size | 120 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: